Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, July 27, 2016
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
[ Wed, Jul 27th 2016
] - WOPRAI
Tue, July 26, 2016
[ Tue, Jul 26th 2016
] - WOPRAI
[ Tue, Jul 26th 2016
] - WOPRAI
[ Tue, Jul 26th 2016
] - WOPRAI
Mon, July 25, 2016
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
[ Mon, Jul 25th 2016
] - WOPRAI
David Nierengarten Initiated (SYRS) at Buy and Held Target at $180 on, Jul 25th, 2016
David Nierengarten of Wedbush, Initiated "Syros Pharmaceuticals, Inc." (SYRS) at Buy and Held Target at $180 on, Jul 25th, 2016.
David has made no other calls on SYRS in the last 4 months.
There is 1 other peer that has a rating on SYRS. Out of the 1 peers that are also analyzing SYRS, all agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Fein of "HC Wainwright & Co." Initiated at Hold and Held Target at $100 on, Monday, July 18th, 2016
